Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Mar. 30, 2024
Dec. 30, 2023
Current assets:    
Cash and cash equivalents $ 4,190 $ 3,933
Short-Term Investments 1,845 1,840
Accounts receivable, net 5,038 5,376
Inventories 4,652 4,351
Receivables from related parties 31 9
Prepaid expenses and other current assets 1,328 1,259
Total current assets 17,084 16,768
Property and equipment, net 1,624 1,589
Operating lease right-of-use assets 632 633
Goodwill 24,262 24,262
Acquisition-related intangibles, net 20,741 21,363
Investment: equity method 106 99
Deferred tax assets 433 366
Other non-current assets 3,013 2,805
Total Assets 67,895 67,885
Current liabilities:    
Accounts payable 1,418 2,055
Payables to related parties 438 363
Accrued liabilities 3,444 3,082
Other current liabilities 424 438
Less: current portion of long-term debt and related unamortized debt premium and issuance costs 750 751
Total current liabilities 6,474 6,689
Long-term debt, net of current portion 1,718 1,717
Long-term operating lease liabilities 530 535
Deferred tax liabiilty 1,199 1,202
Other long-term liabilities 1,776 1,850
Commitments and contingencies (See Note 12)
Capital stock:    
Common stock, par value $0.01; shares authorized: 2,250; shares issued: 1,666 and 1,663; shares outstanding: 1,618 and 1,616 17 17
Additional paid-in capital 60,053 59,676
Treasury stock, at cost (shares held: 48 and 47) (4,690) (4,514)
Retained earnings 846 723
Accumulated other comprehensive loss (28) (10)
Total stockholders’ equity 56,198 55,892
Total liabilities and stockholders’ equity $ 67,895 $ 67,885
Common stock, outstanding (in shares) 1,618 1,616
Common stock, par value (in dollars per share) $ 0.01  
Common stock, authorized (in shares) 2,250  
Common stock, issued (in shares) 1,666 1,663